The World Health Organisation (WHO) agrees that the anti-counterfeit legislation that has been adopted or that is under consideration in East Africa threatens the accessibility of affordable generic medicines according to this report published by IPS Inter Press Sevice. The report follows the recent Kenyan case kindly reported by John Syekei here. Afro-IP generated some helpful comments from co-blogger Paul Asiimwe and others here, one of which was that the Kenyan definition of "counterfeiting" was almost identical to the WHO definition (WHO site -here). Afro Leo has not had the opportunity to compare the texts and would welcome views. Does the WHO admit that its template legislation is flawed?